Anti-PDL1 Therapy

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** An antineoplastic immunotherapy that uses antibodies to disrupt the interaction between human programmed death-ligand 1 (PD-L1; cluster of differentiation 274; CD274) and its receptor, human programmed cell death protein 1 (PD-1; PDCD1; CD279).

**Synonyms:** - Anti-PD(L)1 Therapy - Anti-PD-L1 Therapy - Anti-Programmed Cell Death 1 Ligand 1 Therapy